BioLife Solutions, Inc. (NASDAQ:BLFS) has been assigned a $6.00 target price by equities research analysts at Maxim Group in a research note issued to investors on Friday. The brokerage currently has a “buy” rating on the medical equipment provider’s stock. Maxim Group’s price target points to a potential upside of 57.89% from the company’s current price.

Separately, Janney Montgomery Scott upgraded shares of BioLife Solutions from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $2.62 to $5.00 in a research note on Wednesday, July 5th.

Shares of BioLife Solutions (NASDAQ BLFS) traded up 5.56% on Friday, hitting $3.80. 199,157 shares of the stock were exchanged. The company has a 50-day moving average price of $3.18 and a 200-day moving average price of $2.36. The firm’s market capitalization is $50.27 million. BioLife Solutions has a one year low of $1.43 and a one year high of $3.95.

BioLife Solutions (NASDAQ:BLFS) last issued its quarterly earnings data on Thursday, August 10th. The medical equipment provider reported ($0.06) earnings per share for the quarter, hitting the consensus estimate of ($0.06). BioLife Solutions had a negative net margin of 63.71% and a negative return on equity of 75.24%. The business had revenue of $2.56 million during the quarter, compared to analysts’ expectations of $2.40 million. Equities research analysts expect that BioLife Solutions will post ($0.17) earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “BioLife Solutions, Inc. (NASDAQ:BLFS) PT Set at $6.00 by Maxim Group” was reported by American Banking News and is owned by of American Banking News. If you are accessing this report on another website, it was copied illegally and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at https://www.americanbankingnews.com/2017/08/13/biolife-solutions-inc-nasdaqblfs-pt-set-at-6-00-by-maxim-group.html.

BioLife Solutions Company Profile

BioLife Solutions, Inc (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers.

Receive News & Ratings for BioLife Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.